当前位置:首页 - 行情中心 - 千金药业(600479) - 财务分析

千金药业

(600479)

  

流通市值:44.78亿  总市值:44.78亿
流通股本:4.19亿   总股本:4.19亿

千金药业(600479)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.74亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益316044.41万元,未分配利润121364.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产476220.28万元,负债160175.87万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,817,998,691.421,005,023,395.383,629,804,492.142,714,645,993.63
营业总成本1,636,266,894.81922,900,905.53,317,463,364.572,475,132,343.8
其他经营收益
营业利润195,294,528.7780,038,612.66332,110,652.19240,589,855.67
利润总额194,372,337.5179,470,987.37335,307,574.03241,568,433.39
净利润174,035,961.3972,319,004.16302,608,701.01213,365,044.87
每股收益
其他综合收益524,144.56--13,947.49-75,373.07
综合收益总额174,560,105.9572,319,004.16302,594,753.52213,289,671.8
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,500,492,551.992,539,178,640.442,728,924,172.753,323,017,092.23
非流动资产:
非流动资产合计2,261,710,2022,122,110,290.041,827,373,904.981,130,895,371.64
资产总计4,762,202,753.994,661,288,930.484,556,298,077.734,453,912,463.87
流动负债:
流动负债合计1,516,729,020.741,365,133,748.561,332,793,102.671,296,463,072.2
非流动负债:
非流动负债合计85,029,631.5782,689,619.9184,358,417.2194,162,960.75
负债合计1,601,758,652.311,447,823,368.471,417,151,519.881,390,626,032.95
所有者权益(或股东权益):
归属于母公司股东权益合计2,441,890,460.912,517,440,737.22,462,279,280.072,412,727,770.45
股东权益合计3,160,444,101.683,213,465,562.013,139,146,557.853,063,286,430.92
负债和股东权益合计4,762,202,753.994,661,288,930.484,556,298,077.734,453,912,463.87
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,840,645,307.52892,802,082.874,038,542,875.242,937,284,858.96
经营活动现金流出小计1,885,112,377.021,017,170,9963,639,776,420.642,888,187,185.94
经营活动产生的现金流量净额-44,467,069.5-124,368,913.13398,766,454.649,097,673.02
投资活动产生的现金流量:
投资活动现金流入小计2,722,5002,400,0006,138,020.766,815,990.2
投资活动现金流出小计425,957,906.49294,269,256.26747,320,542.8234,570,536.79
投资活动产生的现金流量净额-423,235,406.49-291,869,256.26-741,182,522.06-27,754,546.59
筹资活动产生的现金流量:
筹资活动现金流入小计5,594,632.232,000,00016,282,452.37-
筹资活动现金流出小计24,448,341.01240,000266,403,772.6226,395,815.36
筹资活动产生的现金流量净额-18,853,708.781,760,000-250,121,320.23-226,395,815.36
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-486,556,184.77-414,478,169.39-592,537,387.69-205,052,688.93
期末现金及现金等价物余额849,238,565.73921,316,581.111,335,794,750.51,723,279,449.26
补充资料:
现金及现金等价物的净增加额-486,556,184.77--592,537,387.69-
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
招商证券梁广楷,欧阳京,许菲菲0.700.871.042025-09-05
TOP↑